Condition
Liver Function Failure
Total Trials
3
Recruiting
1
Active
1
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
Termination Rate
0.0%
0 terminated out of 3 trials
Late-Stage Pipeline
33%
1 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
2Total
P 1 (1)
P 3 (1)
Trial Status
Unknown2
Recruiting1
Clinical Trials (3)
Showing 3 of 3 trials
NCT07797673Phase 1Recruiting
Umbilical Cord Mesenchymal Stem Cell Therapy for Biliary Atresia
NCT04559451UnknownPrimary
Assessment of Remnant Liver Function in ALPPS by Gd-EOB-DTPA Enhanced MRI
NCT03216668Phase 3UnknownPrimary
TONKA Versus Legalon for Lowering Hepatic Enzymes in Liver Function Disorder Patients.
Showing all 3 trials